{"product_id":"evemity-romosozumab-jeringa-prellenada-105mg-1-17ml-con-2","title":"Evenity (Romosozumab) Prefilled Syringe 105mg\/1.17ml With 2","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eBiological Medicine\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eOsteoporosis Treatment\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eEvemity\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eRomosozumab\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003ePre-filled Syringe 105Mg\/1.17Ml With 2\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eAmgen\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eEvemity is indicated for the treatment of osteoporosis in postmenopausal women who are at high risk of fractures. This medication acts as a bone remodeling modulator, helping to increase bone mineral density and reduce the risk of vertebral and non-vertebral fractures. It is recommended to assess the risk of fractures in patients before starting treatment and to consider its use in patients with a history of fractures or with additional risk factors.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach pre-filled syringe contains 105 mg of romosozumab in 1.17 ml of solution. Excipients are: water for injection, sodium chloride, hydrochloric acid and\/or sodium hydroxide to adjust pH.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eEvemity is contraindicated in patients with known hypersensitivity to romosozumab or any of the formulation components. It should not be administered to patients with untreated hypocalcemia or to those with a history of serious cardiovascular events, such as myocardial infarction or stroke in the past year.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of cardiovascular disease, as well as in those with conditions that may predispose to hypocalcemia. It is important to monitor calcium levels before and during treatment with Evemity. Regular medical evaluation is recommended to assess the efficacy of the treatment and the patient's bone health.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in refrigeration between 2°C and 8°C. Do not freeze. Keep out of the reach of children. Do not use after the expiration date indicated on the package.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Amgen","offers":[{"title":"Default Title","offer_id":46299880751329,"sku":"8715131024376","price":15692.31,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/evemity-romosozumab-jeringa-prellenada-105mg-1-17ml-con-2-8715131024376_004c66b9-8e19-4f5f-8c99-b7bb5cceb834.png?v=1744716379","url":"https:\/\/wecarepharma.mx\/en\/products\/evemity-romosozumab-jeringa-prellenada-105mg-1-17ml-con-2","provider":"WeCare Pharma","version":"1.0","type":"link"}